These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 2940604

  • 1. Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390.
    Starr BS, Starr MS.
    Pharmacol Biochem Behav; 1986 Apr; 24(4):837-9. PubMed ID: 2940604
    [Abstract] [Full Text] [Related]

  • 2. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS, Starr MS.
    Neuropharmacology; 1987 Jun; 26(6):613-9. PubMed ID: 2955244
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors.
    Starr BS, Starr MS.
    Neuropharmacology; 1986 May; 25(5):455-63. PubMed ID: 3488514
    [Abstract] [Full Text] [Related]

  • 4. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 5. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 6. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 7. Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors.
    Ichihara K, Nabeshima T, Kameyama T.
    Eur J Pharmacol; 1992 Mar 24; 213(2):243-9. PubMed ID: 1355736
    [Abstract] [Full Text] [Related]

  • 8. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR, Brooderson RJ, White FJ.
    Psychopharmacology (Berl); 1992 Mar 24; 109(1-2):41-8. PubMed ID: 1365670
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of D1 and D2 dopamine receptors produces additive anorectic effects.
    Ladurelle N, Duterte-Boucher D, Costentin J.
    Fundam Clin Pharmacol; 1991 Mar 24; 5(6):481-90. PubMed ID: 1683341
    [Abstract] [Full Text] [Related]

  • 10. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M.
    J Neurochem; 1987 Oct 24; 49(4):1042-9. PubMed ID: 2957468
    [Abstract] [Full Text] [Related]

  • 11. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Feb 24; 20(2):589-97. PubMed ID: 2953990
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptor subtypes and formalin test analgesia.
    Morgan MJ, Franklin KB.
    Pharmacol Biochem Behav; 1991 Oct 24; 40(2):317-22. PubMed ID: 1687167
    [Abstract] [Full Text] [Related]

  • 13. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
    Lublin H, Gerlach J, Peacock L.
    Clin Neuropharmacol; 1992 Dec 24; 15(6):448-58. PubMed ID: 1362136
    [Abstract] [Full Text] [Related]

  • 14. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1995 Feb 24; 117(4):403-12. PubMed ID: 7604140
    [Abstract] [Full Text] [Related]

  • 15. Effects of dopamine D1 and D2 receptor agonists and antagonists on bombesin-induced behaviors.
    Merali Z, Piggins H.
    Eur J Pharmacol; 1990 Dec 04; 191(3):281-93. PubMed ID: 2086245
    [Abstract] [Full Text] [Related]

  • 16. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA, Widzowski DV, Newland MC.
    J Pharmacol Exp Ther; 1989 Sep 04; 250(3):800-8. PubMed ID: 2789282
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA, Callahan PM, Appel JB.
    Eur J Pharmacol; 1985 Dec 10; 119(1-2):121-5. PubMed ID: 2935415
    [Abstract] [Full Text] [Related]

  • 18. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 10; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 19. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1988 Oct 10; 42(25):2561-7. PubMed ID: 3260320
    [Abstract] [Full Text] [Related]

  • 20. Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.
    Ferger B, Kropf W, Kuschinsky K.
    Psychopharmacology (Berl); 1994 Mar 10; 114(2):297-308. PubMed ID: 7838923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.